| Absorption | 50-60 % |
| Volume of distribution |
|
| Protein binding | 82% |
| Metabolism | Hepatic, via microsomal cytochrome P450 (CYP) |
| Route of elimination | Renal elimination of unchanged alosetron accounts for only 6% of the dose. Alosetron is extensively metabolized in humans. |
| Half life | 1.5 hours |
| Clearance |
|
| Toxicity | Not Available |
| Affected organisms |
|
| Pathways | Not Available |
Alosetron
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment